ArticleFrontiers in oncology2021

IDO Inhibition Facilitates Antitumor Immunity of Vγ9Vδ2 T Cells in Triple-Negative Breast Cancer.

Peng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.